基于抗原交叉呈现的癌症免疫疗法的机遇和挑战
Peng Liu1, Zhe Zhou1, Xiaoqiu Su1
1Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, China.
Annals of medicine
|February 27, 2026
概括
瘤细胞通过抑制T细胞激活来逃避免疫反应. 本研究审查了交叉呈现 (XPT) 机制和策略,以增强树突细胞 (DC) 疫苗用于癌症免疫治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 抗瘤免疫依赖于T细胞通过直接瘤抗原呈现或树突细胞 (DC) 交叉呈现 (XPT) 的激活.
- 瘤细胞可以通过降低MHC I的调节和产生免疫抑制因子 (例如PGE2,VEGF,IL-6,IL-10) 来逃避免疫监测.
- 这些因素损害了DC介导的XPT,导致免疫逃避和瘤生长.
研究的目的:
- 审查DC中XPT机制的最新研究.
- 讨论DC疫苗和基于XPT的癌症免疫疗法的进展.
- 为突出克服瘤诱导免疫抑制的策略.
主要方法:
- 对XPT机制的文献综述.
- 关于DC疫苗开发的总结.
- 对针对瘤微环境的新型免疫治疗策略的分析.
主要成果:
- 在DC中已经确定了XPT的多个途径和分子调节器.
- 已经开发了各种DC疫苗以优化XPT和增强T细胞反应.
- 向瘤微环境中的免疫抑制因素显示出改善基于XPT的免疫疗法的前景.
结论:
- 了解XPT及其在DCs中的调节对于有效的癌症免疫治疗至关重要.
- 优化XPT和克服瘤诱导的免疫抑制可以改善癌症的临床治疗方法.
- 对XPT机制和治疗策略的进一步研究有望对抗这种致命疾病.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
4.1K
12:48Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation
Published on: August 21, 2017
8.7K
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Antigens Involved in Adaptive Immunity
1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
Cross-reactivity
33.3K
Overview
33.3K
Antigen Presenting Cells
3.8K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.8K
Antigen Processing Pathways
2.6K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
2.6K
